Description

Synriam 150/750mg Tablet is a pharmaceutical product composed of Arterolen and Piperaquine. It is primarily used for the treatment of malaria caused by Plasmodium falciparum and Plasmodium vivax. The tablet is formulated to provide effective relief and prevent the recurrence of malaria.

Arterolen acts by inhibiting the growth and replication of the malaria parasite, while Piperaquine works by interfering with the parasite’s ability to metabolize and multiply. Together, these components provide a potent antimalarial effect.

The recommended dosage of Synriam Tablet varies depending on the severity of the infection and the patient’s age. It is advised to take the tablet after a meal to enhance its absorption and minimize any potential side effects.

It is important to follow the prescribed dosage and finish the full course of treatment for maximum effectiveness. Potential side effects may include nausea, vomiting, headache, and dizziness. Consult a healthcare professional for more information and guidance.

Additional information